Ian Piggin > Gowling WLG > London, England > Lawyer Profile

Gowling WLG
4 MORE LONDON RIVERSIDE
LONDON
SE1 2AU
England
Ian Piggin photo

Work Department

Corporate/private equity.

Position

Ian is head of the Wragge & Co’s private equity team. He concentrates on private equity transactions for clients including NVM Private Equity, HIG, MML Capital, H2 Capital, Cairngorn Capital, MxP Partners and the Business Growth Fund. He is a member of the firm’s tech and life science sector teams. Recent transactions include: the sale of Convergence Therapeutics Limited for GSK for $650m; the acquisition of Archimedes Pharmaceuticals Limited for Prostrakan for £230m; the acquisition of Amber Taverns Limited for MxP Partners for £85m; the sale of Alaric Systems Limited for NVM for $84m.

Career

Trained Martineau Johnson; qualified 1997; partner Wragge & Co LLP 2006; Wragge Lawrence Graham & Co, partner, 2014.

Education

Sheffield University (Law 2(1)).

Leisure

Gym, squash, walking, motor bikes.

Lawyer Rankings

London > Corporate and commercial > Venture capital

Combining transactional expertise with the industry sector experience of a full service law firm, Gowling WLG derives a significant volume of investor side work from funds, including in the context of renewables and tech venture capital mandates. Although the team handles its fair share of later stage mandates, its sweet-spot lies in advising on early to mid stage financings. Team head Ian Piggin has developed significant expertise in advising international investment syndicates.

London > Corporate and commercial > M&A: lower mid-market deals, £50m-£500m

Widely regarded for the strength of its health and life sciences offering, Gowling WLG is also noted for its transactional capabilities in the real estate, energy, and advanced engineering sectors. Sunil Kakkad also serves as co-head of the firm’s India group, where he works with a host of Indian companies, financial institutions, and investors on cross-border transactions. London M&A head Gareth Baker is a driving force behind the firm’s energy offering, possessing noteworthy expertise in thermal, renewable, and nuclear technologies. Life sciences expert Ian Piggin routinely handles investments and partnerships in the pharmaceutical and medical sectors, while Neil Hendron’s health and care capabilities are concentrated in private company M&A transactions. Senior associate Róisín Bergin advises widely on corporate transactions driven by PE and VC investments.

London > Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)

Gowling WLG acts for sponsors and portfolio companies on a steady stream of investments, mergers, acquisitions and bolt-on deals. The practice is also engaged by growth equity funds, particularly in the renewable energy sector, where Gareth Baker takes the lead. Neil Hendron and Ian Piggin are also key names to note; Piggin leads the team and handles deals across sectors including professional services and technology, while Hendron focuses on the healthcare sector.